Labels, Language and Other Strategies to Improve Communication About Lower Grade Ductal Carcinoma in Situ: Integration of Findings From Theoretical Review and Interviews

Why It Matters

Misaligned terminology fuels confusion and distress, potentially skewing treatment decisions for low‑grade DCIS. Aligning clinician language with patient preferences can lower anxiety and promote truly informed, shared decision‑making.

Key Takeaways

• Women prefer plain terms like “abnormal cells” for low‑grade DCIS
• Clinicians often use technical jargon, creating misunderstanding
• Adapting language reduces anxiety and supports informed choices
• Visual aids and extended consultations improve patient comprehension
• Communication Accommodation Theory guides effective doctor‑patient dialogue

Pulse Analysis

Ductal carcinoma in situ (DCIS) sits at the intersection of early detection and overtreatment, especially for low‑grade lesions that may never become invasive. The diagnostic label itself can trigger alarm, leading many patients to pursue aggressive therapies despite uncertain progression risk. This communication challenge is not merely semantic; it shapes patients’ emotional landscape, influencing everything from anxiety levels to willingness to consider active surveillance. Understanding the psychological weight of medical terminology is therefore a prerequisite for any effort to balance early intervention with patient autonomy.

The recent study leveraged Communication Accommodation Theory (CAT) to dissect how clinicians and patients negotiate meaning across five domains: approximation, interpretability, interpersonal control, discourse management, and emotional regulation. Interviews revealed a clear patient preference for straightforward descriptors—“abnormal cells”—that convey the condition’s nature without invoking the specter of invasive cancer. In contrast, clinicians tended toward terms such as “lesion” or “neoplasm,” which, while accurate, can be perceived as threatening. By aligning language with patient expectations and employing visual aids, clinicians were able to bridge the interpretability gap, fostering a collaborative dialogue that acknowledges uncertainty while preserving trust.

Implementing CAT‑informed strategies has practical implications for breast health services nationwide. Training programs can incorporate plain‑language modules, encouraging providers to pause, check for understanding, and use visual tools that demystify pathology reports. Extended consultation slots allow time for patients to voice concerns and for clinicians to tailor explanations, ultimately reducing the emotional toll of a DCIS diagnosis. As health systems strive for patient‑centred care, refining the lexicon around low‑grade DCIS emerges as a low‑cost, high‑impact lever to improve outcomes and satisfaction.